Why the study?
Does acetazolamide improve urine output in patients with decompensated heart failure and diuretic resistance?
Does acetazolamide improve urine output in patients with decompensated heart failure and diuretic resistance?
Acetazolamide may be an effective adjunct to loop diuretics for managing diuretic resistance in decompensated heart failure.
Answers are grounded in this paper and cite their sources.
Acetazolamide may aid diuresis in diuretic-resistant decompensated HF; single-case observation leaves open need for prospective trials.
Worsening symptoms and fluid overload are the hallmarks of heart failure (HF) decompensation, and fluid removal is central to improvement. Despite high-dose loop diuretics, patients with decompensated HF may develop suboptimal diuresis/diuretic resistance. Sequential nephron blockade with a combination of loop and thiazide/thiazide-like diuretics may be insufficient, resulting in poor outcomes. We present a case wherein urine output improved significantly with acetazolamide. Although the diuretic capacity of acetazolamide is weak on its own, it might be efficient in aiding the efficacy of loop diuretics. We discuss the pathophysiological basis and evidence behind its potential role in diuretic resistance. Drawing from current understanding, we propose a stepwise approach to diuresis in such patients.
No takes yet. Share an insight, caveat, or question.
Gill et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: